Showing results (601-610 of 664) with videos related to

Sort By:
Pageof 67
Frontiers in Microbiology|September 27, 2019
Characterization of the Microbial Resistome in Conventional and "Raised Without Antibiotics" Beef and Dairy Production SystemsPablo Rovira, Tim McAllister, Steven M Lakin, et al.
Plos One|October 5, 2018
Microbial enrichment and gene functional categories revealed on the walls of a spent fuel pool of a nuclear power plantRosane Silva, Darcy Muniz de Almeida, Bianca Catarina Azeredo Cabral, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Nonbenzamidine tetrazole derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.
Nature Communications|February 25, 2022
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomesJakob Woerner, Yidi Huang, Stephan Hutter, et al.
Oncogene|March 1, 2005
Microsatellite instability of selective target genes in HNPCC-associated colon adenomasStefan M Woerner, Matthias Kloor, Annegret Mueller, et al.
Cancer Research|November 17, 2005
Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumorsHafid Alazzouzi, Veronica Davalos, Antti Kokko, et al.
Molecular Neurodegeneration|July 4, 2023
Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson diseaseYogesh Singh, Christoph Trautwein, Joan Romani, et al.
The American Journal of Psychiatry|December 8, 2006
Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomesDelbert G Robinson, Margaret G Woerner, Barbara Napolitano, et al.
Leukemia & Lymphoma|December 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO studyWolfgang Knauf, Jens Uhlig, Eyck von der Heyde, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine careL Sellmann, D Marschner, U M Martens, et al.
Pageof 67